Clinical Trial Update: Cost-Effectiveness of Amphotericin B

View source ↗

Summary

This clinical trial update assesses the cost-effectiveness of amphotericin B for invasive fungal infections, with the study status listed as UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Fungal Infections

Drugs mentioned

• Amphotericin B (Amphotericin B)

Snippet

Sponsor: Hospital Universitario Evangelico de Curitiba | Conditions: Invasive Fungal Infections | Status: UNKNOWN